Inflammation and infection may have the potential to increase the bioavaila
bility of drugs. This effect could be because of a reduced metabolism of xe
nobiotics in the liver and/or the intestines, or because of alterations in
small intestinal permeability, mucosal flow, and expression of drug efflux
transporters such as glycoprotein (Pgp). To assess the impact on intestinal
epithelium of some proinflammatory cytokines and macrophages on permeabili
ty and mRNA expression of CYP3A4 and MDRI (multidrug resistance, coding for
Pgp), we used the Caco-8 cell line os a model. Exposure to proinflammatory
cytokines and macrophages decreased the mRNA expression of CYP3A4 and incr
eased the expression of MDR1 mRNA in the Caco-2 cells. In parallel, the cel
l layer permeability, as measured by sodium fluorescein flux, increased for
all cytokine and macrophage treatments, whereas the effect on transepithel
ial electrical resistance (TEER) varied. Our findings suggest that inflamma
tion and infection trigger several different cellular responses that may af
fect drug bioavailability; that is hampered CYP3A4 expression, increased pe
rmeability of the epithelial cell layer, and enhanced Pgp-mediated countera
ctive transport. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical
Association J Pharm Sci 90:638-646. 2001.